| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1da207a6e5f7ab053fcc4db53008cb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c9ac2f52bc2d0e4e61462a5d7d31dcd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6037 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1271 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00 |
| filingDate |
2011-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be806a6ff662c916ecea052634cd98b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6592831f3d5ad33d27a1c56f0a64cdb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56640a0d798f3b8feb96d659c163dd8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bb3c0370f74d4a8bca767c3859c4774
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aca5307bfa9e6b4b3f9e6bc558c6fef0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_852753af0865058931fbdbd757ef0ed3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24690c79c3599f62094337d1746ea2e4 |
| publicationDate |
2011-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011217312-A1 |
| titleOfInvention |
Targeting poly-gamma-glutamic acid to treat staphylococcus epidermidis and related infections |
| abstract |
Immunogenic compositions and methods for eliciting an immune response against S. epidermidis and other related staphylococci are provided. The immunogenic compositions can include immunogenic conjugates of poly-γ-glutamic acid (such as γDLPGA) polypeptides of S. epidermidis , or related staphylococci that express a γPGA polypeptide. The γPGA conjugates elicit an effective immune response against S. epidermidis , or other staphylococci, in subjects to which the conjugates are administered. A method of treating an infection caused by a Staphylococcus organism that expresses cap genes is also disclosed. The method can include selecting a subject who is at risk of or has been diagnosed with the infection by the Staphylococcus organism which expresses γPGA from the cap genes. Further, the expression of a γPGA polypeptide by the organism can then be altered. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11452291-B2 |
| priorityDate |
2005-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |